Profile
Name
Invesco Biotechnology & Genome ETFAssets under management
$228 millionExpense ratio
0.58%Asset class
EquityDomicile
USInception date
June 23, 2005Net asset value
73K USDWebsite
http://www.invesco.comLast ex-dividend date
September 22, 2025Next ex-dividend date
N/ATop holdings
Name
Weight
5.48 %
4.88 %
4.85 %
4.85 %
4.82 %
4.79 %
4.70 %
4.60 %
4.19 %
3.75 %
3.62 %
3.38 %
3.17 %
3.17 %
3.14 %
2.83 %
2.67 %
2.67 %
2.67 %
2.56 %
2.47 %
2.47 %
2.45 %
2.42 %
2.34 %
2.30 %
2.28 %
2.17 %
2.13 %
2.07 %
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend per share
Dividend yield
Top holdings
Name
Weight
5.48 %
4.88 %
4.85 %
4.85 %
4.82 %
4.79 %
4.70 %
4.60 %
4.19 %
3.75 %
3.62 %
3.38 %
3.17 %
3.17 %
3.14 %
2.83 %
2.67 %
2.67 %
2.67 %
2.56 %
2.47 %
2.47 %
2.45 %
2.42 %
2.34 %
2.30 %
2.28 %
2.17 %
2.13 %
2.07 %
Analyst ratings
FAQ
- Does PBE pay dividends?
- What stocks are in PBE?
- What is the current assets under management for PBE?
- What is PBE average volume?
- What is PBE expense ratio?
- What is PBE inception date?
Does PBE pay dividends?
Yes, the Invesco Biotechnology & Genome ETF does pays dividends, with
the most recent payment being
$0.23
per share. The last ex-dividend date was on September 22, 2025, and the next ex-dividend date has not been announced yet
What stocks are in PBE?
As of today, Invesco Biotechnology & Genome ETF includes 32 holdings, with 30 of them being companies from 2 different countries and 1 sectors. The most weighted holdings are Biogen Inc. (5.48%), Vertex Pharmaceuticals Incorporated (4.88%) and Illumina, Inc. (4.85%)
What is the current assets under management for PBE?
Assets under management of Invesco Biotechnology & Genome ETF is $228M
What is PBE average volume?
Average volume of Invesco Biotechnology & Genome ETF is $8291
What is PBE expense ratio?
Expense ratio of Invesco Biotechnology & Genome ETF is 0.58%
What is PBE inception date?
Inception date of Invesco Biotechnology & Genome ETF is June 23, 2005